Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Private life insurers outpace LIC in new business premium growth
Life insurers saw a 16.6% rise in new business premium during the April-June quarter. Private sector firms expanded faster than LIC, driven by regular premium products. Regular premium collections grew nearly twenty percent year-on-year, while single premium business increased. SBI Life Insurance emerged as the fastest-growing player among listed companies. Private insurers continue gaining market share while LIC retains its dominant position.
Private life insurers outpace LIC in new business premium growth
Life insurers saw a 16.6% rise in new business premium during the April-June quarter. Private sector firms expanded faster than LIC, driven by regular premium products. Regular premium collections grew nearly twenty percent year-on-year, while single premium business increased. SBI Life Insurance emerged as the fastest-growing player among listed companies. Private insurers continue gaining market share while LIC retains its dominant position.
HDFC Life reports 12 per cent premium growth in FY26, retail protection business rises 43 per cent
HDFC Life Insurance reported a robust 12% year-on-year growth in total premium for FY26, with its retail protection business soaring by 43%. The insurer solidified its position among the top three, achieving a 10.8% new business market share. Profit after tax reached Rs 1,910 crore, and assets under management grew to Rs 3.75 lakh crore.
Here's why Godrej Properties, Lodha and shares of other Mumbai-based realtors could be under pressure
Barring Oberoi Realty, which is up 2% for the year, the shares of the other Mumbai-based realtors are down anywhere between 10.5% (Godrej Properties), to as much as 22% (Aditya Birla Real Estate). Shares of Keystone Realtors are down 26% year-to-date, while Mahindra Lifespaces shares are also down 13% for 2026 so far.
Ajanta Pharma promoter sells ₹1,024 crore stake; mutual funds step in as buyers
A promoter entity of Ajanta Pharma has sold a 2.8% stake in the drugmaker for over ₹1,000 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund emerging as the key buyers.
Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MF
A promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund acquiring the stake. The transaction comes amid strong earnings growth, healthy margins and sustained momentum in the company’s pharmaceutical business.
LIC buys Maruti Suzuki shares worth Rs 68 crore, insurer's stake in automaker crosses 5%
Life Insurance Corporation of India (LIC) has increased its stake in Maruti Suzuki above the 5% threshold after purchasing 51,750 shares through a market transaction. The move comes amid a decline in Maruti Suzuki's stock this year and reflects LIC's continued investment activity despite market volatility.
Retail health premium growth rises to 31% YoY in April 2026, anchoring non-life insurance sector: Kotak Institutional Securities
Indian non-life insurance saw robust growth in April 2026. Retail health premiums surged 31 percent year-on-year. Motor insurance also performed well. Private players and standalone health insurers are gaining market share from public sector companies. Commercial lines faced challenges, though marine and engineering segments showed resilience. This indicates a dynamic shift in the insurance landscape.
Aditya Birla Group bets big on IPL boom, says media rights frenzy is far from over
Aditya Birla Group sees strong future growth for Indian sports. The group believes IPL media rights will keep increasing in value. This is despite current worries about fewer bidders. India's economy and sports viewership are rising. Premium sports assets are also scarce. This supports future valuations. The group recently bought Royal Challengers Bengaluru. They are optimistic about the long-term trend.
Buy, Sell Or Hold: Hitachi Energy, JK Tyre, Aditya Birla Capital, PNB, Maruti Suzuki, GAIL — Ask Profit
Buy Sell Hold
Stocks to Watch for May 21: Aditya Birla Capital, Dr Reddy's Lab, Jubilant Food, Bosch India and more
From Dr Reddy's Laboratories announcing the launch of its oral semaglutide biosimilar in India under the brand name Obeda to Whirlpool of India Ltd reporting a 32.7% year-on-year decline in net profit Q4, here are some stocks to track ahead of Thursday trading session.
Canara HSBC Life In Focus as Motilal Oswal Bets on Multi-Year Compounding Story — Check Target Price, Upside
The differentiated dual-bank partnership with mass scale from Canara Bank and premium affluence from HSBC creates a distribution backbone that only a few private life insurers possess.